FDA Debars Man from Drug Industry for Unauthorized Import and Sale of Omeprazole
The Food and Drug Administration issued an order debarring Ashley Brandon Foyle for five years from providing services to any person that has an approved or pending drug product application, in connection with his 2010 conviction for introducing and delivering…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
into commerce a misbranded drug. Foyle had imported omeprazole from Muhi Trading Corporation, and his company Omega Biotech had repackaged and sold the drug. Neither Foyle, Omega, or Muhi Trading were registered to manufacture, prepare, propagate, compound, or process drugs, FDA said.